{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:07:26Z","timestamp":1786993646009,"version":"build-2736575974"},"reference-count":124,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["lrjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.leukres.2014.11.002","type":"journal-article","created":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T14:17:50Z","timestamp":1416579470000},"page":"18-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Malignant hematopoietic cell lines: In vitro models for the study of primary mediastinal B-cell lymphomas"],"prefix":"10.1016","volume":"39","author":[{"given":"Hans G.","family":"Drexler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Ehrentraut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Nagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Eberth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick A.F.","family":"MacLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2014.11.002_bib0005","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/hon.818","article-title":"Primary mediastinal B-cell lymphoma","volume":"25","author":"Boleti","year":"2007","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.leukres.2014.11.002_bib0010","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMra0807082","article-title":"Aggressive lymphomas","volume":"362","author":"Lenz","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2014.11.002_bib0015","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1182\/asheducation-2011.1.506","article-title":"Aggressive B-cell lymphomas: a review of new and old entities in the WHO classification","volume":"2011","author":"Jaffe","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.leukres.2014.11.002_bib0020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1470-2045(02)00714-3","article-title":"Mediastinal (thymic) large B-cell lymphoma: where do we stand?","volume":"3","author":"Barth","year":"2002","journal-title":"Lancet Oncol"},{"issue":"Suppl. 1","key":"10.1016\/j.leukres.2014.11.002_bib0025","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/j.clml.2011.03.029","article-title":"Non-Hodgkin's lymphoma: the old and the new","volume":"11","author":"Cabanillas","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.leukres.2014.11.002_bib0030","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2559.1986.tb02491.x","article-title":"Large cell lymphoma of the mediastinum: a B-cell tumour of probable thymic origin","volume":"10","author":"Addis","year":"1986","journal-title":"Histopathology"},{"key":"10.1016\/j.leukres.2014.11.002_bib0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF00705408","article-title":"Primary mediastinal clear cell lymphoma of B-cell type","volume":"409","author":"M\u00f6ller","year":"1986","journal-title":"Virchows Arch"},{"key":"10.1016\/j.leukres.2014.11.002_bib0040","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/S0140-6736(87)92622-5","article-title":"The human thymus contains a novel population of B lymphocytes","volume":"2","author":"Isaacson","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.leukres.2014.11.002_bib0045","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1182\/blood.V69.4.1087.1087","article-title":"Mediastinal lymphoma of clear cell type is a tumor corresponding to terminal steps of B cell differentiation","volume":"69","author":"M\u00f6ller","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.002_bib0050","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1214561","article-title":"Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma","volume":"368","author":"Dunleavy","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2014.11.002_bib0055","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1200\/JCO.2001.19.6.1855","article-title":"Primary mediastinal B-cell lymphoma: a review of pathology and management","volume":"19","author":"Van Besien","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2014.11.002_bib0060","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1634\/theoncologist.11-5-488","article-title":"Primary mediastinal large B-cell lymphoma","volume":"11","author":"Savage","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.leukres.2014.11.002_bib0065","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.critrevonc.2008.07.020","article-title":"Primary mediastinal large B-cell lymphoma","volume":"68","author":"Martelli","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.leukres.2014.11.002_bib0070","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1182\/asheducation-2008.1.349","article-title":"Primary mediastinal B-cell lymphoma","volume":"2008","author":"Johnson","year":"2008","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.leukres.2014.11.002_bib0075","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1080\/10428190801958994","article-title":"Primary mediastinal B-cell lymphoma: treatment and therapeutic targets","volume":"49","author":"Rodr\u00edguez","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2014.11.002_bib0080","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1182\/blood.V98.9.2762","article-title":"Isotype-switched immunoglobulin genes with a high load of somatic hypermutation and lack of ongoing mutational activity are prevalent in mediastinal B-cell lymphoma","volume":"98","author":"Leith\u00e4user","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.002_bib0085","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0002-9440(10)63815-1","article-title":"Primary mediastinal B-cell lymphoma. High frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins","volume":"162","author":"Pileri","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.leukres.2014.11.002_bib0090","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1080\/1042819042000219467","article-title":"Mutational analysis of IgVH and BCL-6 genes suggests thymic B-cells origin of mediastinal (thymic) B-cell lymphoma","volume":"45","author":"Csernus","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2014.11.002_bib0095","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0065-2776(05)87005-1","article-title":"The biology of human lymphoid malignancies revealed by gene expression profiling","volume":"87","author":"Staudt","year":"2005","journal-title":"Adv Immunol"},{"key":"10.1016\/j.leukres.2014.11.002_bib0100","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/01.pas.0000180856.74572.73","article-title":"Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma","volume":"29","author":"Traverse-Glehen","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.leukres.2014.11.002_bib0105","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3324\/haematol.2010.033167","article-title":"Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma","volume":"96","author":"Eberle","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2014.11.002_bib0110","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1182\/blood-2009-12-257345","article-title":"The molecular pathogenesis of primary mediastinal large B-cell lymphoma","volume":"116","author":"Steidl","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.002_bib0115","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3324\/haematol.2010.030809","article-title":"Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children","volume":"96","author":"Oschlies","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2014.11.002_bib0120","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2014.11.002_bib0125","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2014.11.002_bib0130","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nm0102-68","article-title":"Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning","volume":"8","author":"Shipp","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.leukres.2014.11.002_bib0135","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":"Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.leukres.2014.11.002_bib0140","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","article-title":"The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma","volume":"102","author":"Savage","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.002_bib0145","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1038\/sj.onc.1209151","article-title":"Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation","volume":"25","author":"Weniger","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2014.11.002_bib0150","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/01.pap.0000138144.11635.f8","article-title":"Molecular profiling provides evidence of primary mediastinal large B-cell lymphoma as a distinct entity related to classic Hodgkin lymphoma","volume":"11","author":"Calvo","year":"2004","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.leukres.2014.11.002_bib0155","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood-2005-04-1399","article-title":"Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction","volume":"106","author":"Bea","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.002_bib0160","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/gcc.10016","article-title":"Similar patterns of genomic alterations characterize primary mediastinal large-B-cell lymphoma and diffuse large-B-cell lymphoma","volume":"33","author":"Palanisamy","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.leukres.2014.11.002_bib0165","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/gcc.20495","article-title":"Frequent occurrence of deletions in primary mediastinal B-cell lymphoma","volume":"46","author":"Kimm","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.leukres.2014.11.002_bib0170","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1182\/blood.V87.4.1571.bloodjournal8741571","article-title":"Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene","volume":"87","author":"Joos","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.002_bib0175","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/1098-2264(2001)9999:9999<::AID-GCC1105>3.0.CO;2-I","article-title":"Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL): comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line","volume":"30","author":"Bentz","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.leukres.2014.11.002_bib0180","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/modpathol.2008.207","article-title":"Recurrent numerical aberrations of JAK2 and deregulation of the JAK\u2013STAT cascade in lymphomas","volume":"22","author":"Meier","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.leukres.2014.11.002_bib0185","first-page":"2017","article-title":"Molecular characterization of primary mediastinal B cell lymphoma","volume":"148","author":"Tsang","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.leukres.2014.11.002_bib0190","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1532\/IJH97.E0529","article-title":"Primary mediastinal large B-cell lymphoma: a single-center study of clinicopathologic characteristics","volume":"83","author":"Ostojic Kolonic","year":"2006","journal-title":"Int J Hematol"},{"key":"10.1016\/j.leukres.2014.11.002_bib0195","first-page":"651","article-title":"Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia","volume":"95","author":"Capello","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.002_bib0200","first-page":"1091","article-title":"Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas","volume":"89","author":"Malpeli","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2014.11.002_bib0205","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1038\/sj.leu.2404324","article-title":"Gains of the proto-oncogene BCL11A and nuclear accumulation of BCL11AXL protein are frequent in primary mediastinal B-cell lymphoma","volume":"20","author":"Weniger","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2014.11.002_bib0210","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1038\/sj.leu.2403982","article-title":"Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma","volume":"19","author":"Rossi","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2014.11.002_bib0215","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1182\/blood.V78.3.780.780","article-title":"Evidence of c-myc gene abnormalities in mediastinal large B-cell lymphoma of young adult age","volume":"78","author":"Scarpa","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.002_bib0220","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1365-2141.1999.01678.x","article-title":"Molecular features of primary mediastinal B-cell lymphoma: involvement of p16INK4A, p53 and c-myc","volume":"107","author":"Scarpa","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2014.11.002_bib0225","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/gcc.1133","article-title":"Alteration of chromosome arm 6p is characteristic of primary mediastinal B-cell lymphoma, as identified by genome-wide allelotyping","volume":"31","author":"Rigaud","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.leukres.2014.11.002_bib0230","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/10428190109057953","article-title":"Genetic alterations in primary mediastinal B-cell lymphoma: an update","volume":"41","author":"Scarpa","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2014.11.002_bib0235","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ccr.2010.11.013","article-title":"Cooperative epigenetic modulation by cancer amplicon genes","volume":"18","author":"Rui","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2014.11.002_bib0240","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/(SICI)1098-2264(199911)26:3<203::AID-GCC3>3.0.CO;2-E","article-title":"Nonrandom chromosomal imbalances in primary mediastinal B-cell lymphoma detected by arbitrarily primed PCR fingerprinting","volume":"26","author":"Scarpa","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.leukres.2014.11.002_bib0245","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/blood-2010-05-282780","article-title":"Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma","volume":"116","author":"Green","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.002_bib0250","doi-asserted-by":"crossref","first-page":"13520","DOI":"10.1073\/pnas.0804295105","article-title":"Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways","volume":"105","author":"Lenz","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.leukres.2014.11.002_bib0255","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.immuni.2012.03.017","article-title":"Janus kinase deregulation in leukemia and lymphoma","volume":"36","author":"Chen","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.leukres.2014.11.002_bib0260","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/gcc.20420","article-title":"Gains of REL in primary mediastinal B-cell lymphoma coincide with nuclear accumulation of REL protein","volume":"46","author":"Weniger","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.leukres.2014.11.002_bib0265","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1182\/blood.V99.4.1474","article-title":"Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma","volume":"99","author":"Martin-Subero","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.002_bib0270","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1182\/blood-2002-08-2577","article-title":"Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma","volume":"101","author":"Barth","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.002_bib0275","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1182\/blood-2004-09-3701","article-title":"Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line","volume":"105","author":"Melzner","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.002_bib0280","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1038\/leu.2008.85","article-title":"STAT6 activity is regulated by SOCS-1 and modulates BCL-XL expression in primary mediastinal B-cell lymphoma","volume":"22","author":"Ritz","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2014.11.002_bib0285","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1182\/blood-2009-03-209759","article-title":"Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma","volume":"114","author":"Ritz","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.002_bib0290","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1182\/blood-2009-05-221770","article-title":"STAT6 in PMBL: pathogenic or passenger?","volume":"114","author":"Frank","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.002_bib0295","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nature09754","article-title":"MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers","volume":"471","author":"Steidl","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2014.11.002_bib0300","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.2900","article-title":"Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma","volume":"46","author":"Gunawardana","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.leukres.2014.11.002_bib0305","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1182\/blood-2013-10-535443","article-title":"Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma","volume":"123","author":"Twa","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.002_bib0310","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1084\/jem.20090528","article-title":"TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma","volume":"206","author":"Schmitz","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.leukres.2014.11.002_bib0315","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1038\/sj.leu.2404919","article-title":"Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH)","volume":"21","author":"Wessendorf","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2014.11.002_bib0320","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1038\/sj.onc.1201735","article-title":"Defective I\u03baB\u03b1 in Hodgkin cell lines with constitutively active NF-\u03baB","volume":"16","author":"Wood","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2014.11.002_bib0325","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1084\/jem.191.2.395","article-title":"Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma","volume":"191","author":"Jungnickel","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.leukres.2014.11.002_bib0330","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2141.2004.05000.x","article-title":"Mutational analysis of the IkBalpha gene in activated B cell-like diffuse B-cell lymphoma","volume":"126","author":"Thomas","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2014.11.002_bib0335","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1182\/blood-2005-07-2827","article-title":"Lack of IKBA coding region mutations in primary mediastinal large B-cell lymphoma and the host response subtype of diffuse large B-cell lymphoma","volume":"107","author":"Takahashi","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.002_bib0340","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/ijc.24502","article-title":"Mutations of NFKBIA, encoding IkappaB alpha, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases","volume":"125","author":"Lake","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.leukres.2014.11.002_bib0345","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/gcc.20789","article-title":"Rare occurrence of biallelic CYLD gene mutations in classical Hodgkin lymphoma","volume":"49","author":"Schmidt","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.leukres.2014.11.002_bib0350","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1097\/01.MP.0000032534.81894.B3","article-title":"MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas","volume":"15","author":"Copie-Bergman","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.leukres.2014.11.002_bib0355","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1182\/blood.V94.10.3567.422k06_3567_3575","article-title":"The MAL gene is expressed in primary mediastinal large B-cell lymphoma","volume":"94","author":"Copie-Bergmann","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.002_bib0360","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1182\/blood-2002-07-2215","article-title":"Interleukin 4-induced gene 1 is activated in primary mediastinal large B-cell lymphoma","volume":"101","author":"Copie-Bergmann","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.002_bib0365","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1084\/jem.194.12.1861","article-title":"Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells","volume":"194","author":"Davis","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.leukres.2014.11.002_bib0370","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1182\/blood-2004-12-4901","article-title":"NFkB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes","volume":"106","author":"Feuerhake","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.002_bib0375","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1158\/1078-0432.28.11.1","article-title":"Small molecular inhibitors of I\u03baB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling","volume":"11","author":"Lam","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.leukres.2014.11.002_bib0380","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/sj.leu.2403702","article-title":"Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphoma","volume":"19","author":"Marafioti","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2014.11.002_bib0385","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/modpathol.3800440","article-title":"Expression of TP73L is a helpful diagnostic marker of primary mediastinal large B-cell lymphomas","volume":"18","author":"Zam\u00f2","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.leukres.2014.11.002_bib0390","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.humpath.2009.05.009","article-title":"Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas","volume":"40","author":"Miles","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.leukres.2014.11.002_bib0395","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.pas.0000213334.40358.0e","article-title":"Expression of TRAF1 and nuclear c-Rel distinguishes primary mediastinal large cell lymphoma from other types of diffuse large B-cell lymphoma","volume":"31","author":"Rodig","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.leukres.2014.11.002_bib0400","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1002\/ijc.24652","article-title":"Identification of a chemokine receptor profile characteristic for mediastinal large B-cell lymphoma","volume":"125","author":"Rehm","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.leukres.2014.11.002_bib0405","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1182\/blood-2003-10-3545","article-title":"Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma","volume":"104","author":"Guiter","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.002_bib0410","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1182\/blood.V99.2.618","article-title":"Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed\u2013Sternberg cells of Hodgkin lymphoma","volume":"99","author":"Skinnider","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.002_bib0415","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/sj.leu.2404594","article-title":"High expression of several tyrosine kinases and activation of the PI3K\/AKT pathway in mediastinal large B cell lymphoma reveals further similarities to Hodgkin lymphoma","volume":"21","author":"Renn\u00e9","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2014.11.002_bib0420","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1182\/blood-2011-09-381905","article-title":"FOXO1 is a tumor suppressor in classical Hodgkin lymphoma","volume":"119","author":"Xie","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.002_bib0425","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.18632\/oncotarget.2107","article-title":"FOXO1 downregulation contributes to the oncogenic program of primary mediastinal B-cell lymphoma","volume":"5","author":"Xie","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.leukres.2014.11.002_bib0430","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/(SICI)1098-2744(199908)25:4<256::AID-MC4>3.0.CO;2-W","article-title":"Correlation of poly(ADP-ribose)polymerase and p53 expression levels in high-grade lymphomas","volume":"25","author":"Menegazzi","year":"1999","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.leukres.2014.11.002_bib0435","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1182\/blood.V84.10.3422.3422","article-title":"B-cell non-Hodgkin's lymphoma cell line (Karpas 1106) with complex translocation involving 18q21.3 but lacking BCL2 rearrangement and expression","volume":"84","author":"Nacheva","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.002_bib0440","series-title":"Guide to leukemia\u2013lymphoma cell lines","author":"Drexler","year":"2010"},{"key":"10.1016\/j.leukres.2014.11.002_bib0445","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3109\/10428199209053591","article-title":"Farage, a novel early B cell lymphoma cell line with trisomy 11","volume":"6","author":"Ben-Bassat","year":"1992","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2014.11.002_bib0450","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3109\/10428199609093448","article-title":"Molecular characterization of an unusual non-Hodgkin B-lymphoma cell line (\u201cFarage\u201d) lacking the ability to produce immunoglobulin polypeptide chains","volume":"21","author":"Baruch","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2014.11.002_bib0455","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature10688","article-title":"FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas","volume":"481","author":"Duan","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2014.11.002_bib0460","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1600-0609.1999.tb01766.x","article-title":"Somatic mutations and intraclonal variations in the rearranged Vk genes of B-non-Hodgkin's lymphoma cell lines","volume":"63","author":"Gabay","year":"1999","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.leukres.2014.11.002_bib0465","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.20062041","article-title":"Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma","volume":"19","author":"Lenz","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.leukres.2014.11.002_bib0470","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3109\/10428190109060355","article-title":"Regulation of the expression of CD45 isoforms in the Farage human B cell lymphoma line and its 10.6.1 subline","volume":"41","author":"Rabinowitz","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2014.11.002_bib0475","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0165-2478(93)90066-B","article-title":"The effect of IL-4 on the phenotype of a human B-cell lymphoma line (Farage) lacking immunoglobulin","volume":"36","author":"Shubinsky","year":"1993","journal-title":"Immunol Lett"},{"key":"10.1016\/j.leukres.2014.11.002_bib0480","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.exphem.2009.11.005","article-title":"Interleukin-13 stimulation of the mediastinal B-cell lymphoma cell line Karpas-1106P induces a phenotype resembling the Hodgkin lymphoma cell line L1236","volume":"38","author":"Andersson","year":"2010","journal-title":"Exp Hematol"},{"key":"10.1016\/j.leukres.2014.11.002_bib0485","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.21485","article-title":"Biallelic deletion within 16p13.13 including SOCS-1 in Karpas1106P mediastinal B-cell lymphoma line is associated with delayed degration of JAK2 protein","volume":"118","author":"Melzner","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.leukres.2014.11.002_bib0490","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/sj.leu.2404036","article-title":"Absence of the JAK V617F activating mutation in classical Hodgkin lymphoma and primary mediastinal B-cell lymphoma","volume":"20","author":"Melzner","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2014.11.002_bib0495","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/sj.leu.2403741","article-title":"Homozygous deletion of SOCS1 in primary mediastinal B-cell lymphoma detected by CGH to BAC microarrays","volume":"19","author":"Mestre","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2014.11.002_bib0500","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1182\/blood-2006-06-026500","article-title":"Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas","volume":"109","author":"Mestre-Escorihuela","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.002_bib0505","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1038\/bcj.2014.61","article-title":"KIT mutations in primary mediastinal B-cell lymphoma","volume":"4","author":"Nagel","year":"2014","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.leukres.2014.11.002_bib0510","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1182\/blood-2002-10-3236","article-title":"MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma","volume":"101","author":"Sanchez-Izquierdo","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.002_bib0515","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3816\/CLM.2008.n.049","article-title":"Differential expression of cysteinyl leukotriene receptor 1 and 15-lipoxygenase-1 in non-Hodgkin lymphomas","volume":"8","author":"Schain","year":"2008","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.leukres.2014.11.002_bib0520","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1182\/blood.V85.4.893.bloodjournal854893","article-title":"Deletions and rearrangement of CDKN2 in lymphoid malignancy","volume":"85","author":"Stranks","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.002_bib0525","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/(SICI)1097-0215(19980925)78:1<100::AID-IJC16>3.0.CO;2-F","article-title":"Delineation of the breakpoint at 18q21.1 in a cell line (KARPAS1106) derived from mediastinal B-cell lymphoma by fluorescence in situ hybridization with multiple YAC clones","volume":"78","author":"Tamura","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1016\/j.leukres.2014.11.002_bib0530","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/path.1825","article-title":"BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas","volume":"207","author":"Kluiver","year":"2005","journal-title":"J Pathol"},{"key":"10.1016\/j.leukres.2014.11.002_bib0535","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/sj.leu.2405083","article-title":"MicroRNA expression in lymphocyte development and malignancy","volume":"22","author":"Lawrie","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2014.11.002_bib0540","doi-asserted-by":"crossref","first-page":"283","DOI":"10.18632\/oncoscience.35","article-title":"Knock-down of BCL6\/STAT6 sensitizes primary B cell lymphoma cells for treatment with current therapeutic agents","volume":"1","author":"H\u00e4berle","year":"2014","journal-title":"Oncoscience"},{"key":"10.1016\/j.leukres.2014.11.002_bib0545","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.18632\/oncotarget.1149","article-title":"STAT6-mediated BCL6 repression in primary mediastinal B-cell lymphoma (PMBL)","volume":"4","author":"Ritz","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.leukres.2014.11.002_bib0550","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ijc.1211","article-title":"MedB-1, a human tumor cell line derived from a primary mediastinal large B-cell lymphoma","volume":"92","author":"M\u00f6ller","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.leukres.2014.11.002_bib0555","first-page":"549","article-title":"Genomic imblance including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells","volume":"60","author":"Joos","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2014.11.002_bib0560","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1158\/0008-5472.CAN-10-2987","article-title":"Dynamic mathematical modeling of IL13-induced signaling in Hodgkin and primary mediastinal B-cell lymphoma allows prediction of therapeutic targets","volume":"71","author":"Raia","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2014.11.002_bib0565","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/ijc.21417","article-title":"U-2940, a human B-cell line derived from a diffuse large cell lymphoma sequential to Hodgkin lymphoma","volume":"118","author":"Sambade","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.leukres.2014.11.002_bib0570","doi-asserted-by":"crossref","first-page":"20798","DOI":"10.1073\/pnas.0806491106","article-title":"Compensatory IKKalpha activation of classical NK-kappaB signaling during IKK\u03b2 inhibition by an RNA interference sensitization screen","volume":"105","author":"Lam","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.leukres.2014.11.002_bib0575","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1172\/JCI200316624","article-title":"Identification of Hodgkin and Reed\u2013Sternberg cell-specific genes by gene expression profiling","volume":"111","author":"K\u00fcppers","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.leukres.2014.11.002_bib0580","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1038\/sj.leu.2401894","article-title":"Karyotypic dissection of Hodgkin's disease cell lines reveals ectopic subtelomeres and ribosomal DNA at sites of multiple jumping translocations and genomic amplification","volume":"14","author":"MacLeod","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2014.11.002_bib0585","first-page":"741","article-title":"Chromothripsis in Hodgkin lymphoma","volume":"72","author":"Nagel","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.leukres.2014.11.002_bib0590","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1182\/blood.V98.12.3413","article-title":"The BCL11 gene family: involvement of BCL11A in lymphoid malignancies","volume":"98","author":"Satterwhite","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.002_bib0595","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/ijc.10845","article-title":"Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2","volume":"103","author":"Joos","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.leukres.2014.11.002_bib0600","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3324\/haematol.11073","article-title":"A detailed inventory of DNA copy number alterations in four commonly used Hodgkin's lymphoma cell lines","volume":"92","author":"Feys","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2014.11.002_bib0605","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1158\/1078-0432.CCR-13-3007","article-title":"Selective JAK2 inhibition specifically decreases Hodgkin lymphoma and mediastinal large B-cell lymphoma growth in vitro and in vivo","volume":"20","author":"Hao","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.leukres.2014.11.002_bib0610","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1309\/63H1A83HRTBQ07DB","article-title":"Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma","volume":"129","author":"Martini","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.leukres.2014.11.002_bib0615","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1182\/blood-2012-06-437210","article-title":"Primary mediastinal large B-cell lymphoma segregating in a family: exome sequencing identifies MLL as a candidate predisposition gene","volume":"121","author":"Saarinen","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.11.002_bib0620","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/sj.leu.2402799","article-title":"False leukemia\u2013lymphoma cell lines: an update on over 500 cell lines","volume":"17","author":"Drexler","year":"2003","journal-title":"Leukemia"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212614003336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212614003336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T03:49:30Z","timestamp":1717559370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212614003336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":124,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0145212614003336"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2014.11.002","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Malignant hematopoietic cell lines: In vitro models for the study of primary mediastinal B-cell lymphomas","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2014.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}